Search Results - "Albertini, M.R."

34P Heterogeneous response to immune checkpoint inhibitors in metastatic melanoma patients: Assessment of lesion-level response with 18F-FDG PET/CT by Strašek, K., Huff, D., N.Hribernik, Zurbriggen, L., Doma, A., Lawrence, E.M., Studen, A., Ma, V.T., Fernandes, V. Santoro, Albertini, M.R., Zevnik, K., Škalič, K., Reberšek, M., Jeraj, R.

Get full text

Intratumoral injection of IL-12 plasmid DNA - results of a phase I IB clinical trial by Mahvi, D M, Henry, M B, Albertini, M R, Weber, S, Meredith, K, Schalch, H, Rakhmilevich, A, Hank, J, Sondel, P

“…Effective eradication of established tumor and generation of a lasting systemic immune response are the goals of cancer immunotherapy. The objective of this…”
Get full text